世界の滅菌有効成分市場予測 2021年-2026年

【英語タイトル】Global Sterile Active Pharmaceutical Ingredients Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9657)・商品コード:LPI21MY9657
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:134
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「滅菌有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、水性、非水性液体、乾燥粉末、その他など、用途別には、CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他などにセグメント区分してまとめました。滅菌有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・滅菌有効成分の世界市場概要(サマリー)
・滅菌有効成分の企業別販売量・売上
・滅菌有効成分の企業別市場シェア
・滅菌有効成分の世界市場規模 2016年-2021年:種類別(水性、非水性液体、乾燥粉末、その他)
・滅菌有効成分の世界市場規模 2016年-2021年:用途別(CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他)
・滅菌有効成分の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・滅菌有効成分のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・滅菌有効成分のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・滅菌有効成分の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・滅菌有効成分市場の成長要因・課題・動向
・滅菌有効成分の世界市場予測 2021年-2026年
・滅菌有効成分の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・滅菌有効成分のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・滅菌有効成分のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・滅菌有効成分の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・滅菌有効成分の世界市場予測:種類別(水性、非水性液体、乾燥粉末、その他)
・滅菌有効成分の世界市場予測:用途別(CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Sterile Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Sterile Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Sterile Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Active Pharmaceutical Ingredients market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Aqueous
Non-aqueous Liquid
Dry Powder
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Aurobindo Pharma
Teva Pharmaceutical Industries
Corden Pharma
Dalton Pharma Services
Pfizer
Sun Pharmaceutical Industries
Lonza Group
Albany Molecular Research
Sanofi
Dr. Reddy’s Laboratories

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sterile Active Pharmaceutical Ingredients Consumption 2016-2026
2.1.2 Sterile Active Pharmaceutical Ingredients Consumption CAGR by Region
2.2 Sterile Active Pharmaceutical Ingredients Segment by Type
2.2.1 Aqueous
2.2.2 Non-aqueous Liquid
2.2.3 Dry Powder
2.2.4 Others
2.3 Sterile Active Pharmaceutical Ingredients Sales by Type
2.3.1 Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
2.3.2 Global Sterile Active Pharmaceutical Ingredients Revenue and Market Share by Type (2016-2021)
2.3.3 Global Sterile Active Pharmaceutical Ingredients Sale Price by Type (2016-2021)
2.4 Sterile Active Pharmaceutical Ingredients Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Genitourinary/Hormonal Drugs
2.4.4 Respiratory
2.4.5 Rheumatology
2.4.6 Diabetes
2.4.7 Oncology
2.4.8 Others
2.5 Sterile Active Pharmaceutical Ingredients Sales by Application
2.5.1 Global Sterile Active Pharmaceutical Ingredients Sale Market Share by Application (2016-2021)
2.5.2 Global Sterile Active Pharmaceutical Ingredients Revenue and Market Share by Application (2016-2021)
2.5.3 Global Sterile Active Pharmaceutical Ingredients Sale Price by Application (2016-2021)

3 Global Sterile Active Pharmaceutical Ingredients by Company
3.1 Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Company
3.1.1 Global Sterile Active Pharmaceutical Ingredients Sales by Company (2019-2021)
3.1.2 Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Company (2019-2021)
3.2 Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company
3.2.1 Global Sterile Active Pharmaceutical Ingredients Revenue by Company (2019-2021)
3.2.2 Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company (2019-2021)
3.3 Global Sterile Active Pharmaceutical Ingredients Sale Price by Company
3.4 Global Manufacturers Sterile Active Pharmaceutical Ingredients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sterile Active Pharmaceutical Ingredients Product Location Distribution
3.4.2 Players Sterile Active Pharmaceutical Ingredients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Sterile Active Pharmaceutical Ingredients by Region
4.1 Global Sterile Active Pharmaceutical Ingredients by Region
4.1.1 Global Sterile Active Pharmaceutical Ingredients Sales by Region
4.1.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Region
4.2 Americas Sterile Active Pharmaceutical Ingredients Sales Growth
4.3 APAC Sterile Active Pharmaceutical Ingredients Sales Growth
4.4 Europe Sterile Active Pharmaceutical Ingredients Sales Growth
4.5 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Growth

5 Americas
5.1 Americas Sterile Active Pharmaceutical Ingredients Sales by Country
5.1.1 Americas Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
5.1.2 Americas Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
5.2 Americas Sterile Active Pharmaceutical Ingredients Sales by Type
5.3 Americas Sterile Active Pharmaceutical Ingredients Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Sterile Active Pharmaceutical Ingredients Sales by Region
6.1.1 APAC Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021)
6.1.2 APAC Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021)
6.2 APAC Sterile Active Pharmaceutical Ingredients Sales by Type
6.3 APAC Sterile Active Pharmaceutical Ingredients Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Sterile Active Pharmaceutical Ingredients by Country
7.1.1 Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
7.1.2 Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
7.2 Europe Sterile Active Pharmaceutical Ingredients Sales by Type
7.3 Europe Sterile Active Pharmaceutical Ingredients Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Sterile Active Pharmaceutical Ingredients by Country
8.1.1 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021)
8.1.2 Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021)
8.2 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type
8.3 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sterile Active Pharmaceutical Ingredients Distributors
10.3 Sterile Active Pharmaceutical Ingredients Customer

11 Global Sterile Active Pharmaceutical Ingredients Market Forecast
11.1 Global Sterile Active Pharmaceutical Ingredients Forecast by Region
11.1.1 Global Sterile Active Pharmaceutical Ingredients Forecast by Regions (2021-2026)
11.2.2 Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Sterile Active Pharmaceutical Ingredients Forecast by Type
11.7 Global Sterile Active Pharmaceutical Ingredients Forecast by Application

12 Key Players Analysis
12.1 Aurobindo Pharma
12.1.1 Aurobindo Pharma Aurobindo Pharma Company Information
12.1.2 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product Offered
12.1.3 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Aurobindo Pharma Main Business Overview
12.1.5 Aurobindo Pharma Latest Developments
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Company Information
12.2.2 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
12.2.3 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Pharmaceutical Industries Main Business Overview
12.2.5 Teva Pharmaceutical Industries Latest Developments
12.3 Corden Pharma
12.3.1 Corden Pharma Company Information
12.3.2 Corden Pharma Sterile Active Pharmaceutical Ingredients Product Offered
12.3.3 Corden Pharma Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Corden Pharma Main Business Overview
12.3.5 Corden Pharma Latest Developments
12.4 Dalton Pharma Services
12.4.1 Dalton Pharma Services Company Information
12.4.2 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product Offered
12.4.3 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Dalton Pharma Services Main Business Overview
12.4.5 Dalton Pharma Services Latest Developments
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Sterile Active Pharmaceutical Ingredients Product Offered
12.5.3 Pfizer Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Pfizer Main Business Overview
12.5.5 Pfizer Latest Developments
12.6 Sun Pharmaceutical Industries
12.6.1 Sun Pharmaceutical Industries Company Information
12.6.2 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
12.6.3 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Sun Pharmaceutical Industries Main Business Overview
12.6.5 Sun Pharmaceutical Industries Latest Developments
12.7 Lonza Group
12.7.1 Lonza Group Company Information
12.7.2 Lonza Group Sterile Active Pharmaceutical Ingredients Product Offered
12.7.3 Lonza Group Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Lonza Group Main Business Overview
12.7.5 Lonza Group Latest Developments
12.8 Albany Molecular Research
12.8.1 Albany Molecular Research Company Information
12.8.2 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product Offered
12.8.3 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Albany Molecular Research Main Business Overview
12.8.5 Albany Molecular Research Latest Developments
12.9 Sanofi
12.9.1 Sanofi Company Information
12.9.2 Sanofi Sterile Active Pharmaceutical Ingredients Product Offered
12.9.3 Sanofi Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sanofi Main Business Overview
12.9.5 Sanofi Latest Developments
12.10 Dr. Reddy’s Laboratories
12.10.1 Dr. Reddy’s Laboratories Company Information
12.10.2 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product Offered
12.10.3 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Dr. Reddy’s Laboratories Main Business Overview
12.10.5 Dr. Reddy’s Laboratories Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Sterile Active Pharmaceutical Ingredients Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Aqueous
Table 3. Major Players of Non-aqueous Liquid
Table 4. Major Players of Dry Powder
Table 5. Major Players of Others
Table 6. Global Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 7. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 8. Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2016-2021) & ($ million)
Table 9. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
Table 10. Global Sterile Active Pharmaceutical Ingredients Sale Price by Type (2016-2021)
Table 11. Global Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 12. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 13. Global Sterile Active Pharmaceutical Ingredients Value by Application (2016-2021)
Table 14. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2021)
Table 15. Global Sterile Active Pharmaceutical Ingredients Sale Price by Application (2016-2021)
Table 16. Global Sterile Active Pharmaceutical Ingredients Sales by Company (2019-2021) & (Kiloton)
Table 17. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Company (2019-2021)
Table 18. Global Sterile Active Pharmaceutical Ingredients Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company (2019-2021)
Table 20. Global Sterile Active Pharmaceutical Ingredients Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Sterile Active Pharmaceutical Ingredients Producing Area Distribution and Sales Area
Table 22. Players Sterile Active Pharmaceutical Ingredients Products Offered
Table 23. Sterile Active Pharmaceutical Ingredients Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021) (Kiloton)
Table 27. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 28. Global Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Table 30. Americas Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
Table 31. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 32. Americas Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 34. Americas Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 35. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 36. Americas Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 37. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 38. APAC Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (Kiloton)
Table 39. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 40. APAC Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Table 42. APAC Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 43. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 44. APAC Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 45. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 46. Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
Table 47. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 48. Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 50. Europe Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 51. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 52. Europe Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 53. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (Kiloton)
Table 55. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021) & (Kiloton)
Table 59. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021) & (Kiloton)
Table 61. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 62. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026) & (Kiloton)
Table 63. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Sterile Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026) & (Kiloton)
Table 67. Global Sterile Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Sterile Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2021-2026)
Table 70. Aurobindo Pharma Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 71. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product Offered
Table 72. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 73. Aurobindo Pharma Main Business
Table 74. Aurobindo Pharma Latest Developments
Table 75. Teva Pharmaceutical Industries Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 76. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
Table 77. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 78. Teva Pharmaceutical Industries Main Business
Table 79. Teva Pharmaceutical Industries Latest Developments
Table 80. Corden Pharma Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 81. Corden Pharma Sterile Active Pharmaceutical Ingredients Product Offered
Table 82. Corden Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 83. Corden Pharma Main Business
Table 84. Corden Pharma Latest Developments
Table 85. Dalton Pharma Services Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 86. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product Offered
Table 87. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 88. Dalton Pharma Services Main Business
Table 89. Dalton Pharma Services Latest Developments
Table 90. Pfizer Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Sterile Active Pharmaceutical Ingredients Product Offered
Table 92. Pfizer Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Sun Pharmaceutical Industries Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 96. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product Offered
Table 97. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 98. Sun Pharmaceutical Industries Main Business
Table 99. Sun Pharmaceutical Industries Latest Developments
Table 100. Lonza Group Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 101. Lonza Group Sterile Active Pharmaceutical Ingredients Product Offered
Table 102. Lonza Group Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 103. Lonza Group Main Business
Table 104. Lonza Group Latest Developments
Table 105. Albany Molecular Research Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 106. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product Offered
Table 107. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 108. Albany Molecular Research Main Business
Table 109. Albany Molecular Research Latest Developments
Table 110. Sanofi Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 111. Sanofi Sterile Active Pharmaceutical Ingredients Product Offered
Table 112. Sanofi Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 113. Sanofi Main Business
Table 114. Sanofi Latest Developments
Table 115. Dr. Reddy’s Laboratories Basic Information, Sterile Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 116. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product Offered
Table 117. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 118. Dr. Reddy’s Laboratories Main Business
Table 119. Dr. Reddy’s Laboratories Latest Developments
List of Figures
Figure 1. Picture of Sterile Active Pharmaceutical Ingredients
Figure 2. Sterile Active Pharmaceutical Ingredients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sterile Active Pharmaceutical Ingredients Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Sterile Active Pharmaceutical Ingredients Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Sterile Active Pharmaceutical Ingredients Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Aqueous
Figure 10. Product Picture of Non-aqueous Liquid
Figure 11. Product Picture of Dry Powder
Figure 12. Product Picture of Others
Figure 13. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 14. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
Figure 15. Sterile Active Pharmaceutical Ingredients Consumed in CNS
Figure 16. Global Sterile Active Pharmaceutical Ingredients Market: CNS (2016-2021) & (Kiloton)
Figure 17. Sterile Active Pharmaceutical Ingredients Consumed in Cardiovascular
Figure 18. Global Sterile Active Pharmaceutical Ingredients Market: Cardiovascular (2016-2021) & (Kiloton)
Figure 19. Sterile Active Pharmaceutical Ingredients Consumed in Genitourinary/Hormonal Drugs
Figure 20. Global Sterile Active Pharmaceutical Ingredients Market: Genitourinary/Hormonal Drugs (2016-2021) & (Kiloton)
Figure 21. Sterile Active Pharmaceutical Ingredients Consumed in Respiratory
Figure 22. Global Sterile Active Pharmaceutical Ingredients Market: Respiratory (2016-2021) & (Kiloton)
Figure 23. Sterile Active Pharmaceutical Ingredients Consumed in Rheumatology
Figure 24. Global Sterile Active Pharmaceutical Ingredients Market: Rheumatology (2016-2021) & (Kiloton)
Figure 25. Sterile Active Pharmaceutical Ingredients Consumed in Diabetes
Figure 26. Global Sterile Active Pharmaceutical Ingredients Market: Diabetes (2016-2021) & (Kiloton)
Figure 27. Sterile Active Pharmaceutical Ingredients Consumed in Oncology
Figure 28. Global Sterile Active Pharmaceutical Ingredients Market: Oncology (2016-2021) & (Kiloton)
Figure 29. Sterile Active Pharmaceutical Ingredients Consumed in Others
Figure 30. Global Sterile Active Pharmaceutical Ingredients Market: Others (2016-2021) & (Kiloton)
Figure 31. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Figure 32. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application in 2020
Figure 33. Global Sterile Active Pharmaceutical Ingredients Revenue Market by Company in 2020 ($ Million)
Figure 34. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Company in 2020
Figure 35. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Regions (2016-2021)
Figure 36. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
Figure 37. Americas Sterile Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 38. Americas Sterile Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 39. APAC Sterile Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 40. APAC Sterile Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 41. Europe Sterile Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 42. Europe Sterile Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales 2016-2021 (Kiloton)
Figure 44. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue 2016-2021 ($ Millions)
Figure 45. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 46. Americas Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 47. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 48. Americas Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 49. United States Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 50. Canada Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 51. Mexico Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 52. Brazil Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 53. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
Figure 54. APAC Sterile Active Pharmaceutical Ingredients Revenue Market Share by Regions in 2020
Figure 55. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 56. APAC Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 57. China Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 58. Japan Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 59. Korea Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 60. Southeast Asia Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 61. India Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 62. Australia Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 63. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 64. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 65. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 66. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 67. Germany Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 68. France Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 69. UK Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 70. Italy Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 71. Russia Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 72. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country in 2020
Figure 73. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country in 2020
Figure 74. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 75. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 76. Egypt Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 77. South Africa Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 78. Israel Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 79. Turkey Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 80. GCC Country Sterile Active Pharmaceutical Ingredients Revenue Growth 2016-2021 ($ Millions)
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles


★調査レポート[世界の滅菌有効成分市場予測 2021年-2026年] (コード:LPI21MY9657)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の滅菌有効成分市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆